Enanta Pharmaceuticals, Inc.
USD11.24
-0.79 (-6.57%)
CEO
Jay R. Luly
IPO Date
2013-03-21
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$11.92
Prev. Close
$12.03
Day Low
$11.17
Day High
$12.03
52W Low
$6.43
52W High
$17.15
Market Cap
$0.26B
Volume
0.37M
| 30 Sept 2025 |
| WestPark Capital |
| Buy |
| Buy |
| maintain |
| 15 Sept 2025 | Evercore ISI Group | Outperform | Outperform | maintain |
| 12 Aug 2025 | JMP Securities | Market Outperform | Market Outperform | maintain |
| 3 Jun 2025 | JMP Securities | Market Outperform | Market Outperform | maintain |
| 14 May 2025 | JMP Securities | Market Outperform | Market Outperform | maintain |
| 11 Feb 2025 | JMP Securities | Market Outperform | Market Outperform | maintain |
| 11 Feb 2025 | HC Wainwright & Co. | Buy | Buy | maintain |